Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,461 | -1,303 | -955 | -1,125 | -1,293 |
| Depreciation Amortization | 2 | 1 | 18 | 21 | 16 |
| Other Working Capital | -228 | 456 | -25 | 7 | -899 |
| Other Operating Activity | 0 | 1 | 20 | 91 | -53 |
| Operating Cash Flow | $-1,686 | $-845 | $-942 | $-1,007 | $-2,229 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 712 |
| PPE Investments | -5 | -2 | N/A | -3 | -1 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 728 |
| Investing Cash Flow | $-5 | $-2 | $N/A | $-3 | $1,439 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,425 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $2,425 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 5 | -8 | -9 | -43 | 95 |
| Beginning Cash Position | 8 | 863 | 1,821 | 2,835 | 2,659 |
| End Cash Position | 746 | 8 | 870 | 1,783 | 1,964 |
| Net Cash Flow | $738 | $-856 | $-951 | $-1,052 | $-695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,686 | -845 | -942 | -1,007 | -2,229 |
| Capital Expenditure | -5 | -2 | N/A | -3 | -1 |
| Free Cash Flow | -1,691 | -848 | -942 | -1,010 | -2,230 |